Ephedrine
| Ephedrine | |
|---|---|
| Salts [] | |
|---|---|
| Ephedrine hydrochloride | |
| Ephedrine tartrate | |
| Ephedrine hemihydrate | |
| Ephedrine hemisulfate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 165.23 g/mol [1] |
| Appearance | Waxy solid, crystals or granules [1] |
| Density | 1.0085 g/cu cm at 22 °C [1] |
| Melting point | 34 °C [1] |
| Boiling point | 255 °C [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of /nitrogen oxides/ [1] |
| Solubility | 63600 mg/L (at 30 °C) [1] |
| Predicted LogP | 0.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H15NO |
| IUPAC name | (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol |
| SMILES | C[C@@H]([C@@H](C1=CC=CC=C1)O)NC |
| InChI | InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1 |
| InChIKey | KWGRBVOPPLSCSI-WPRPVWTQSA-N |
| CAS number | 299-42-3 |
| UNII | GN83C131XS |
| PubChem CID | 9294 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Oral: 15–60 minutes, Intramuscular injection: 10–20 minutes, Intravenous administration: Rapid |
| Elimination half-life | 6 hours[3] |
| Duration of action | Oral: 2–4 hours, IV/IM: 60 minutes |
| Metabolism | Largely unmetabolized |
| Excretion | Mainly urine (60% unchanged) |
| Routes of administration | By mouth, intravenous (IV), intramuscular (IM), subcutaneous (SC) |
| Dependence liability | *Physiological: Low *Psychological: Moderate |
| Addiction liability | Moderate[4] |
| Toxicity [] | |
|---|---|
| LD50 | Mice: - oral: 812 mg/kg - oral: 1,072 mg/kg Rat: - sc: 300 mg/kg - oral: 600 mg/kg [1] |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Threshold | 1 - 2 |
| Light | 2 - 10 |
| Common | 10 - 25 |
| Strong | 25 - 50 |
| Heavy | 50 - 75 |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Ephedrine (also known as l-Ephedrine, (-)-Ephedrine, Ephedrin, Mandrin, Ephedrol, Sanedrine, Biophedrin, Ephedremal, Ephedrital or Ephedrosan) is a sympathomimetic substance of the amphetamine and phenylethanolamine class.
Chemistry
Salts []
Stereochemistry []
Ephedrine is a single defined stereoisomer (optical activity ( - )).
Druglikeness
Lipinski's rule of five
Ephedrine matches Lipinski's rule of five.Reagents
There are currently 10 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | brown or clear | |
| Mandelin | short reddish | |
| Liebermann | yellow > orange > red | |
| Froehde | brown or clear | |
| Robadope | no pink color change | |
| Simon's | no blue color change | |
| Ehrlich | no color change | |
| Hofmann | no color change | |
| Scott | no color change |
Pharmacology
ATC Classification
- cardiovascular system (C)
- cardiac therapy (C01)
- cardiac stimulants excl. cardiac glycosides (C01C)
- adrenergic and dopaminergic agents (C01CA)
- (C01CA26)
- ephedrine (C01CA26)
- respiratory system (R)
- nasal preparations (R01)
- decongestants and other nasal preparations for topical use (R01A)
- sympathomimetics, plain (R01AA)
- ephedrine (R01AA03)
- sympathomimetics, combinations excl. corticosteroids (R01AB)
- ephedrine (R01AB05)
- drugs for obstructive airway diseases (R03)
- adrenergics for systemic use (R03C)
- alpha- and beta-adrenoreceptor agonists (R03CA)
- ephedrine (R03CA02)
- sensory organs (S)
- ophthalmologicals (S01)
- mydriatics and cycloplegics (S01F)
- sympathomimetics excl. antiglaucoma preparations (S01FB)
- ephedrine (S01FB02)
MeSH Classification
- central nervous system stimulants (M0001063)
- sympathomimetics (M0020947)
- vasoconstrictor agents (M0022551)
- adrenergic agents (M0027961)
Mechanism of action []
Ephedrine is a direct and indirect sympathomimetic amine. As a direct effect, ephedrine activates alpha-adrenergic and beta-adrenergic receptors. As an indirect effect, it inhibits norepinephrine reuptake and increases the release of norepinephrine from vesicles in nerve cells. These actions combined lead to larger quantities of norepinephrine present in the synapse for more extended periods of time, increasing stimulation of the sympathetic nervous system. Ephedrine acts as an agonist of alpha-1, beta-1 and beta-2-adrenergic receptors. The stimulation of alpha-1-adrenergic receptors causes the constriction of veins and a rise in blood pressure, the stimulation of beta-1-adrenergic receptors increases cardiac chronotropy and inotropy, and the stimulation of beta-2-adrenergic receptors causes vasodilation and bronchodilation. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| ADRB1 | shared target | 9 (3 contraindicated) |
|---|---|---|
| ADRB2 | shared target | 7 (3 contraindicated) |
| ADRB3 | shared target | 4 (3 contraindicated) |
| ADRA1A | shared target | 3 (1 contraindicated) |
| ADRA1B | shared target | 3 (1 contraindicated) |
| ADRA1D | shared target | 3 (1 contraindicated) |
| ADRA2A | shared target | 2 (2 contraindicated) |
| ADRA2B | shared target | 2 (2 contraindicated) |
| ADRA2C | shared target | 2 (2 contraindicated) |
Medical side effects []
50 side effects listed on drug labels in SIDER 4.1 (ephedrine).
- Angina pectoris
- Decreased appetite
- Anxiety
- Arrhythmia
- Asthenia
- Confusional state
- Feeling abnormal
- Delirium
- Dizziness
- Lightheadedness
- Dyspnoea
- Dysuria
- Dermatitis
- Rash
- Body temperature increased
- Hallucination
- Headache
- Hypertension
- Irritability
- Nausea
- Nervousness
- Tension
- Pain
- Pallor
- Palpitations
- Psychotic disorder
- Paranoia
- Muscle spasms
- Hyperhidrosis
- Tachycardia
- Tremor
- Trembling
- Ventricular fibrillation
- Vertigo
- Vomiting
- Urinary retention
- Acute retention of urine
- Agitation
- Dyspepsia
- Nasal dryness
- Chest pain
- Euphoric mood
- Prostatism
- Dependence
- Extrasystoles
- Bradycardia
- Blood pressure increased
- Insomnia
- Benign prostatic hyperplasia
- Cerebral haemorrhage
Indications
- Adams-Stokes syndrome
- Asthma
- Atrioventricular block complete
- Bronchospasm
- Cardiac disorder
- Headache
- Hypersensitivity
- Hypertension
- Hypotension
- Hypotensive
- Myasthenia gravis
- Narcolepsy
- Nasal congestion
- Rhinorrhoea
- Shock
- Sinus pain
- Swelling
Subjective effects []
Experience reports
Erowid
There are currently 30 experience reports involving ephedrine on Erowid: []- "Fluctuant Intangi-Tweaking" by Vyevissorex
- "Strung Out and Frenetic" by meluzine
- "24-Hour Headache" by Morpheus
- "Up All Night Afterwards" by Zam
- "Another Good Euphoric Stimulant" by Zam
- "Pseudo-Speedball" by The Candyman
- "42rd hr Delirium" by Sleepless Llama
- "Yellow Jackets" by Trucker speed
- "Worst Night Ever" by Coach
- "Beta Blockers Are an Essential Tool!" by Raoul Duke
- "Sick to my Stomach" by Anonymous
- "Wie Vier Besessene..." by Spaceflower
- "Friendly but a Bit Confused" by Lennart J.
- "Double Double Toil and Trouble..." by Komrade
- "Speed Lite" by MrMoran
- "Feeling Warm and Thinking Clearly" by morgana
- "Speed in All Its Many Forms" by The Moderator
- "More Fun Than Expected" by oelcsm
- "4 Hours of Ephedrine" by anon
- "Calm Productivity" by ZenPuppy
- "Double Sensation" by Sillywabbit33
- "Hangover That Never Seems To Go Away" by JZArtist
- "Perfect Pick Me Up" by AboveTheDust
- "Tingling Goodness" by Don
- "As Was Expected" by Garbage
- "Herbal Ecstasy" by Jackflash
- "A Profound Sense Of Dread" by Don
- "Oh, How It Made The Day Fly By" by Anonymous
- "Hopeless Case" by amr
- "So High for So Long" by Amelia
Legal status []
- Australia: Ephedrine is a Schedule 4.
- Brazil: Ephedrine is a D1.[5]
- Canada: Ephedrine is a Schedule VI.
- United Kingdom: Ephedrine is Prescription only / P.[6][7]
- United States: Ephedrine is Prescription only / OTC.[8][9]
- European Union: Ephedrine is Prescription only / OTC.
- Other: Ephedrine is a SE: Rx-only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 9294, Ephedrine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/9294
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ephedrine. UNII: GN83C131XS. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GN83C131XS
Ephedrine: Uses, Interactions, Mechanism of Action. DrugBank Online. 29 April 2016. https://go.drugbank.com/drugs/DB01364
Ephedrine addiction: development, symptoms, diagnosis. Ankerhuisrehab.com. September 20, 2025. https://ankerhuisrehab.com/addiction/types/substances/drugs/ephedrine/
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Ephedrine Hydrochloride 15mg Tablets Summary of Product Characteristics (SmPC). emc. https://www.medicines.org.uk/emc/product/2577/smpc
Ephedrine Nasal Drops 1.0% Summary of Product Characteristics (SmPC). emc. 11 March 2015. https://www.medicines.org.uk/emc/product/4840/smpc
Akovaz- ephedrine sulfate injection. DailyMed. 16 April 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25828db2-4942-4f7c-a0d5-dc66f82cfb71
Title 21: Food And Drugs Part 341—Cold, Cough, Allergy, Bronchodilator, And Antiasthmatic Drug Products For Over-The-Counter Human Use. Electronic Code of Federal Regulations. https://ecfr.federalregister.gov/current/title-21/chapter-I/subchapter-D/part-341/subpart-C/section-341.80
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 09:00:46 |
| drugspro | ok | 2026-11-20 09:00:42 |
| erowid | ok | 2026-11-20 09:00:44 |
| gsrs | ok | 2026-11-20 09:00:47 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015451) | 2026-11-20 09:00:42 |
| kegg | ok | 2026-11-20 09:00:44 |
| pubchem | ok | 2026-11-20 09:00:42 |
| ok | 2026-11-20 09:00:42 | |
| sider | ok | 2026-11-20 09:00:42 |
| structure | ok | 2026-11-20 09:00:42 |
| wikipedia | ok | 2026-11-20 09:00:43 |